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Abstract: The two main applications of silica-based materials in medicine and biotechnology, i.e. for bone-repairing de-
vices and for drug delivery systems, are presented and discussed. The influence of the structure and chemical composition 
in the final characteristics and properties of every silica-based material is also shown as a function of the both applications 
presented. The adequate combination of the synthesis techniques, template systems and additives leads to the development 
of materials that merge the bioactive behavior with the drug carrier ability. These systems could be excellent candidates as 
materials for the development of devices for tissue engineering. 
1. INTRODUCTION 
  The ceramics for medical practice have been traditionally 
classified into two main groups, those inert materials such as 
alumina, zirconia or carbon [1,2] and those that undergo a 
specific interaction with the physiological environment when 
are implanted that leads to the material integration in the 
living tissue. These latter materials are known as bioactive 
ceramics and include some calcium phosphates,[3]. glasses 
and glass-ceramics [4]. In the latter area of research in the 
biomedical field, the silica-based ceramics receive a great 
interest. The first materials to be considered bioactive were 
certain compositions of silica-based glasses, leading to the 
development of a wide area of research on new silica materi-
als for biomedical applications. It can be assumed bioactivity 
as the ability that show certain materials, with a definite 
chemical composition and structure, when are submitted to 
the physiological environment, which consists in a series of 
chemical processes in the material-living tissue interface that 
leads to the material incorporation into the living tissue. 
Such processes are verified through the nucleation and 
growth on the material surface of a layer of carbonated hy-
droxyapatite with low-crystallinity and close-related to the 
mineral phase of bone tissues.  
  This process was first described by Hench et al. in the 
1970s [5] in some compositions of silica glasses. Since then 
many studies, comprising different glasses and calcium sili-
cate compositions, have shown in vitro bioactivity [6,7]. 
Although the mechanism of apatite formation has not been 
completely elucidated, the presence of silanol groups in the 
surface seems to be crucial. In this sense, several authors 
propose that silanol groups act as nucleation sites. However, 
there are more factors compulsory for apatite formation [8]; 
among them, it is interesting to point out the textural proper-
ties, i.e. those related with the porosity. It has been proved 
that there is a direct relation between both pore size and vol-
ume and the nucleation rate of the apatite layer [9]. 
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  Further insights in the research on silica-based materials 
are the bioactive organic-inorganic hybrids, which show also 
interesting properties for clinical applications [10-15]. Hard 
tissues in vertebrates are natural composite materials, there-
fore the synthesis of such composites seems to be a quite 
reasonable approach to imitate Nature in the laboratory. 
However, the scope of the silica materials with clinical ap-
plications has considerably changed in the latest years. For 
instance, it is worth mentioning the research effort carried 
out in mesoporous materials for designing biomedical de-
vices with two main uses, drug delivery systems and bone 
tissue regeneration [16,17]. This double perspective of the 
mesoporous materials, the proper combination of the bioac-
tive behavior of silica with the open texture and ordered po-
rosities, has propelled the research in this area in the latest 
years. Moreover, the so-called templated glasses have been 
obtained using surfactants as structure directing agents [18].  
 
 
 
 
 
 
 
 
 
Fig. (1). Scheme of the main families of silica-based materials used 
for biomedical applications. 
  Summarizing, the two main landmarks in the use of sil-
ica-based ceramics in biomedicine are the development of 
materials useful for tissue regeneration and in drug delivery 
systems. Both research areas are strongly related, as it can be 
observed in the current literature and nowadays bioactive 
materials can be designed with the drug release properties. 
The fact is the relationship between different areas has lead 
to the opening of the research scope on silica materials for 
biomedical applications. In this sense, in order to help in the 
making of the present review article and to facilitate the 
reading and understanding, the scheme in Fig. (1) is in-2    The Open Biomedical Engineering Journal, 2008, Volume 2  Vallet-Regí and Balas 
cluded. In that, the diverse applications in biomedicine of the 
different silica-based materials will be presented and dis-
cussed. 
2. AMORPHOUS SILICA SPHERES 
  Monodispersed silica spheres having a homogeneous 
diameter in the sub-micrometer range can be used as a start-
ing material for building devices having a wide range of 
technological applications [19-21]. From a different perspec-
tive, sub-micrometer sized silica spheres can be surface func-
tionalized with different organic ligands and, by doing so, 
the field is opened to practical applications in chromatogra-
phy, selective separations and biological immunoassays [22], 
to mention only a few examples. On the other hand, silica 
microbeads can easily be incorporated into micro fluidic 
devices, thus enhancing the sensitivity for detection of trace 
amounts of biological molecules. 
  The simplest way to synthesize silica with spherical 
shape is the Stöber method [23]. Using this procedure 
spheres can be synthesized in a large variety of sizes by con-
trolling the pH conditions in the synthetic environment. Fig. 
(2) shows that Stöber silica microspheres show very homo-
geneous particle sizes and at microstructure level are amor-
phous. This can be assured by the broad and diffuse electron 
scattering rings observed in the electron diffraction (ED) 
pattern. The Fourier-transform filtered image (Fig. 2) shows 
that several local crystalline and quasi-crystalline blocks can 
detected in the silica spheres, which are in agreement with 
the distribution of SiO2 clusters in silica-based amorphous 
materials used for biomedical applications [13,16]. Moreo-
ver, the pore volume and diameter of the silica microspheres 
is usually lower that that found for silica in bulk state, which 
is usually attributed to the fractal dimension of the surface of 
spheres. In such case, the surface is held in the outermost 
surface of materials, as it has been shown by using small 
angle X-ray scattering studies [24]. 
 
 
 
 
 
 
Fig. (2). TEM image of SiO2 microspheres obtained by the Stöber 
method. The HR-TEM image shows the microstructure of SiO2. 
  The surface of silica spheres that can be synthesized us-
ing sol-gel techniques is highly reactive and therefore can be 
modified by functionalization with the adequate organic rea-
gents. This latter process is generally used for producing an 
active layer for the adsorption of molecules for drug delivery 
applications. For these purposes, the silica spheres serve as 
vectors for transporting the desired drug molecule through 
the vascular system to the desired target organ [25,26]. 
2.1. Nanospheres of SiO2-Fe2O3 
  Silica spheres in the nanometric range easily can be di-
rected through the human body if the spherical particles 
show any characteristic that can be externally controlled. In 
this sense, the development of magnetic nanoparticles is also 
focusing the attention of many researchers because of their 
broad range of possible applications in not only in electron-
ics, catalysis, and magnetic memories,[27,28]. but also in 
biomedicine [29]. In this latter area, the magnetic nano-
spheres have been used for magnetic bioseparations [30], 
hyperthermia of tumors [31], contrast agents for magnetic 
resonance imaging (MRI) [32] and for designing drug carri-
ers [33]. Magnetic nanoparticles as drug delivery vectors 
provide the ability to selectively target the desired organs or 
tissues inside the body, as well as accumulate a certain con-
centration of nanoparticles along the therapy path by means 
of the application of an external magnetic field. 
  The process to incorporate magnetic species into the sil-
ica spherical particles has to be performed for avoiding the 
direct contact between the magnetic core and the tissue while 
keeping the stability of the colloid in the biological environ-
ment. The most successful attempts to carry out this kind of 
silica nanospheres are the aerosol-assisted routes [34,35]. 
Fig. (3) shows the microstructure and magnetic characteriza-
tion of silica spheres encapsulating maghemite nanoparticles 
[36]. It can be observed that the magnetization curves of the 
encapsulated nanoparticles are characteristic of a superpar-
amagnetic material in agreement with the small size of the 
magnetic cores in the silica spheres.
 The superparamagnetic 
behavior is particularly valuable for hyperthermia, where the 
nanoparticles could generate heat as a result of a combina-
tion of Néel and Brownian mechanisms [37]. 
 
 
 
 
 
 
 
 
 
Fig. (3). TEM images of SiO2·-Fe2O3 nanospheres obtained by 
pyrosol method. The arrows indicate the situation of the -Fe2O3 
nanoparticles in the silica matrix. Magnetization curve and ibupro-
fen release profile are also shown. 
3. BIOGLASSES 
  According to Zachariasen [38], a glass is a substance 
which can form extended three dimensional networks lack-
ing periodicity with energy content comparable with that of 
the corresponding crystal network. In essence, the density 
and the mechanical properties of glass are solid-like; how-
ever, the atoms form a continuous random network such that 
the unit cell (in crystal structure terminology) is infinitely 
large, containing an infinite number of atoms. A working 
definition of glass is that it is a solid with a liquid-like struc-
ture [39]. 
  The characteristic amorphicity of these glasses is gener-
ally a product of the structure of silicate glass, usually de-
fined by [SiO4] tetrahedra. While crystallised silica shows a 
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pected of any crystalline material, this is not the case in silica 
glass. Indeed, for the generation of a glass it is needed a net-
work forming agent, for which the tetrahedral silica units is 
an outstanding candidate. In addition, silica shows enhanced 
characteristics for developing bioactive materials, as it has 
been mentioned in the Introduction. 
  A common feature of both the crystalline -i.e., quartz- 
and the amorphous structures is that each oxygen ion links 
two tetrahedra, although forming a more open arrangement 
in the case of amorphous silica. Such a rather open structure 
facilitates the inclusion of cations referred to as network 
modifiers, and this feature allows a wide range of silica 
glasses to be obtained. 
  The presence of cations, such as Na
+, K
+ and Ca
2+, in the 
glass causes a discontinuity of the glassy network through 
the disruption of some siloxane bridging bonds (Si-O-Si). As 
a consequence, non-bridging oxygen is released. Tradition-
ally, for the melt glasses, the objective of such network 
modifiers was there to break a proportion of those bonds, 
thus allowing the melt to solidify with a high degree of dis-
order. Its presence provided lower melting temperatures and 
viscosity values, reducing the economic costs of glass pro-
duction, while ensuring a high degree of disorder. 
  Nevertheless, such disordered structure, enhanced by the 
presence of network modifiers, gives rise to the high reactiv-
ity of these glasses in aqueous environments. This high reac-
tivity is the main advantage of their application in periodon-
tal repair and bone augmentation, since it enhances the bio-
active behavior in physiological fluids resulting in the crys-
tallization of the apatite-like phase [40-42]. Early bioactive 
glasses were prepared by the classic quenching of melts 
comprising SiO2 and P2O5 as network formers and CaO and 
Na2O as network modifiers [5]. In the early 1990s, sol-gel 
processing was introduced for the synthesis of bioactive 
glasses [43], allowing higher purity and homogeneity in the 
compositions as well as longer ranges of textural properties 
[44]. 
 
 
 
 
 
 
 
 
 
Fig. (4). SEM and TEM images of the surface of 80Si17Ca3P glass 
after 3 days of soaking in SBF at 37ºC. Right side image shows the 
transversal cut of the material showing the aggregates of the apatite 
layer formed on the surface of the bioactive glass. 
  The bioactive behavior of the sol-gel glasses has been 
extensively shown since the early 1990s in a wide variety of 
silica-based compositions [6,45-48], even with modifications 
in the synthesis procedure [49]. Fig. (4) shows the transmis-
sion electron microscopy (TEM) and scanning electron mi-
croscopy (SEM) images of a sol-gel bioglass composed by 
80% SiO2, 17% CaO and 3% P2O5; the so-called 80Si17Ca3P 
composition after immersion in a simulated body fluid (SBF) 
for 7 days at 37ºC [50]. As it can be seen, the surface is fully 
covered by a layer of crystalline aggregates. More informa-
tion on this layer can be drawn from the high-resolution 
TEM images, where it can be observed that such aggregates 
are formed by needle-like nanocrystals with sizes about 50 
nm. Electron diffraction patterns show that the observed 
crystalline phase can be identified as apatite similar to the 
bone mineral phase. Moreover, Fig. (4) also shows that the 
thickness of the deposited apatite layer is thicker than 2 μm 
and is tightly bonded to the substrate. 
  Although the bioactivity of glasses is a very interesting 
property of the materials in order to design devices for pros-
thetic applications, the sol-gel glasses show poor mechanical 
properties. As it can be seen in Fig. (5), the fracture tough-
ness of sol gel glasses, regardless of the bioactive character, 
is very low to be considered for repairing large bone defects. 
In this sense, two alternatives have been proposed to enhance 
the mechanical properties of the materials with bioactive 
behavior; the bioactive glass ceramics and the Star-gels. 
 
 
 
 
 
 
 
 
Fig. (5). Comparison of the fracture toughness of sol-gel glass, 
glass ceramics and Star gels. For sol-gel glasses, the inset show the 
formation of spherical aggregates, which composition is closely 
related to that of the bone apatite. In the case of glass-ceramics, the 
formation of the aggregates of bonelike apatite layer is dependent 
of the soluble areas in the surface responsible for the bioactivity and 
the borders between aggregates are due to non-bioactive insoluble 
areas. For star-gels, the TEM image of the inset shows the amor-
phous nature of the materials with quasi-crystalline nuclei similar to 
the apatite and responsible for the bioactive behavior. 
3.1. Bioactive Glass-Ceramics 
  A glass ceramic is defined as material where one or sev-
eral crystal phases are embedded in a glassy matrix, which 
covers at least the 90% of the total volume of the material. In 
the special case of silica-based glassy matrices, the applica-
tion of glass ceramics was particularly remarkable in the 
biomedical world. The earlier reports of Kokubo in the 
1980s centered the attention to these materials as potential 
candidates for the production of prosthetic devices with a 
good bioactive behavior. The most interesting material 
within this type was composed of apatite and wollastonite 
(A-W glass-ceramic), which showed not only bioactivity but 
also improved mechanical properties compared to those of 
pure glassy systems. In Fig. (5) are depicted the averaged 
fracture toughness of the glass ceramics. Due to this im-
provement of the mechanical resistance, glass ceramics have 
been proposed for prosthetic devices in load-bearing condi-
tions. 4    The Open Biomedical Engineering Journal, 2008, Volume 2  Vallet-Regí and Balas 
  Actually, the bioactive properties of glass-ceramics are 
more difficult to predict than those of glasses, especially in 
vivo. Hench [51] developed three different microstructural 
45S5 compositions: glass, partially crystalline and fully crys-
talline, and after 6 weeks in vivo all the implants were 
bonded to the cortical bone of a rat femur, proving that the 
presence of a silica phase is enough for a noticeable bioactiv-
ity. Moreover, further research shown that the A-W glass 
ceramic also bonds to living bone by means of a layer rich in 
calcium phosphates, although with no silica gel layer de-
tected at the implant-bone interface. Apparently, the pres-
ence of crystalline phases can be a hindrance to the bioactive 
behavior of glass-ceramics [52]. 
  However, the research done on bioactive glass ceramics 
in the latest years have produced several new compositions, 
in which the good mechanical properties are conserved but 
the bioactivity has reached values comparable to those of 
sol-gel glasses [6,53,54]. These novel glass ceramics are 
obtained by properly merging together the knowledge in the 
synthesis of sol-gel glasses, which are used as precursors, 
with heating and annealing procedures common in the prepa-
ration of melt glasses. The obtained glass ceramics, there-
fore, show microstructural characteristics close to those of 
parent sol-gel glasses that improve the bioactivity and, 
moreover, the mechanical behavior is equivalent to that of 
the classical A-W based systems. 
3.2. Star Gels  
  In 1995 DuPont Corp. developed a novel series of silica 
based materials that were called star gels [55]. Star gels are a 
type of organic–inorganic hybrid with a unique structure of 
an organic core surrounded by flexible arms, which are ter-
minated in alkoxysilane groups. At the macroscopic level, 
star gels exhibit an intermediate behavior, in terms of me-
chanical properties, between conventional glasses and highly 
cross-linked rubbers. Currently, star gels are still one of the 
most interesting subjects in the field of hybrid materials [56]. 
The synthesis of materials able to integrate with bone while 
preserving the mechanical properties of star gels, would 
mean a very important advance in materials science for bio-
medical applications. These materials can be excellent can-
didates for bone tissue regeneration when star gels are ob-
tained as monoliths of different shapes in order to fit into any 
kind of medium or large bone defect. In addition, the star 
gels must be structurally homogeneous so that their biologi-
cal and mechanical response when implanted can be safely 
predicted and, finally, star gels must be able to develop an 
apatite-like phase in contact with physiological fluids, i.e. 
must be bioactive. 
  Bioactive star gels can be obtained as monoliths of any 
shape and size and are able to develop an apatite phase on 
their surface when soaked in simulated body fluid. Morpho-
logically and structurally are homogeneous and are far better 
than conventional bioactive glasses from a mechanical point 
of view. Therefore, bioactive star gels could be excellent 
candidates for osseous regeneration in medium and large 
bone defects [57]. In addition, as it can be seen in Fig. (5), 
the fracture toughness of the bioactive star-gels are much 
better than those of sol-gel glasses and close related to the 
fracture toughness of the cortical bone. 
4. ORDERED MESOPOROUS SILICA 
  Ordered mesoporous silica-based materials constitute an 
amazing family of solids that show ordered arrangements of 
pores as channels and cavities with different geometries built 
up from [SiO4] tetrahedra. The pore sizes of these materials 
are always very homogeneous ranging from 2 to 50 nm and 
can be controlled and modified, in a reasonable extension, 
using several synthetic strategies [58,59]. The most common 
an well-known ordered mesoporous frameworks are the 2D 
hexagonal planar, with symmetry group p6mm, MCM-41 
[58] and SBA-15 [59] structures with pores around 2 and 10 
nm, respectively, and the 3D-cubic MCM-48 [58], with 
symmetry group Ia3d with pore size about 3 nm.  
  The most important feature of these materials, from a 
practical point of view, is the feasibility of synthesize the 
mesoporous frameworks with various different pore sizes 
and geometries. This fact opens a wide range of possibilities 
for hosting molecules larger than the ones exhibited in the 
traditional microporous host materials; the zeolites and re-
lated materials. This is of great interest for designing materi-
als able to be used as drug carriers, since the pore size of 
these materials are similar in magnitude to the molecular size 
of drugs. In view of all of these facts, mesoporous materials 
have been developed as drug delivery systems since 2001 
[60]. The importance of these materials as drug carriers is 
based on the ability of the silanol groups in the mesopore 
walls to adsorb molecules of pharmacological interest, fol-
lowed by a potentially controlled release that depends of 
several factors [61,62]. These pioneer works have opened 
new directions in the research on drug delivery systems 
based in ordered mesoporous silica [63-71]. In Fig. (6) is 
depicted an scheme of the kind of drug molecules that can be 
adsorbed in the pores of ordered mesoporous silicas. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Schematic representation of the adsorption of drug mole-
cules (ibuprofen, alendronate, erythromycin, gentamicin, vancomy-
cin and cis-platin) into a hexagonally ordered mesoporous material. 
  The adsorption capacity of the silica walls between adja-
cent pores can be modulated through functionalization with 
different chemical species depending on the molecule to be 
adsorbed. The chemical modification of the surface of 
mesoporous materials is a common strategy for modulating 
the surface properties and the performance in the desired 
conditions. The literature of mesoporous materials holds a 
huge amount of functionalization procedures over different 
inorganic matrices. The main functionalization procedures Silica Materials for Medical Applications  The Open Biomedical Engineering Journal, 2008, Volume 2    5 
currently in use are the co-condensation procedure [72], in 
which the organic functional group is mixed with the silica 
precursors and all the procedure is carried out in the same 
reaction vessel; and the post-synthesis grafting method [73], 
where the already formed inorganic silica matrix is reacted 
with the functionalizating agent in anhydrous conditions to 
yield organically modified silica mesopores. Chemically 
grafting functional groups on the ordered mesoporous net-
work originates a noticeable change in the adsorption charac-
teristics of the silica surface as well as in its polarity. The 
chemical modification of the silanol groups at the pore walls 
has to be selected depending on the drug molecule to get the 
desired loading and release [74]. 
  The influence of the chemical interaction between silica 
matrix and drug molecule on the adsorption and delivery rate 
of drugs in functionalized mesoporous materials has been 
further investigated [75]. The wide range of available modi-
fications helps to select the more suitable organic group de-
pending on the drug to be confined and delivered. This fact 
evidences the possibility of designing the mesoporous matrix 
depending on the molecule to be adsorbed and delivered, and 
also depending on the dosage and release kinetics desired for 
a given therapy. Therefore, several factors influence in the 
final adsorption properties of the mesoporous silicas, when 
intended for developing materials for drug delivery. These 
factors are schematically shown in Fig. (7). 
 
 
 
 
 
 
 
 
 
 
Fig. (7). Scheme of the factors that affect to the properties of or-
dered mesoporous silica. 
  Essentially, the process of drug adsorption on the surface 
of mesopores is carried out by soaking the silica mesoporous 
solid in a solution containing the drug at certain conditions. 
In Fig. (8) can be observed that the adsorption of gentamicin, 
a well-known antibiotic, into the pores of SBA-15 does not 
modify the mesoporous hexagonal planar ordering [64]. On 
the other hand, the drug release tests are carried out by im-
mersing the drug-loaded samples into a buffered solution 
that mimicks the conditions in the human plasma. Moreover, 
as it can be also seen in Figure 8, the mesoporous structure 
of SBA-15 does not undergo any modification after releasing 
the drug. This indicates that the mesoporous structures are 
stable for loading and releasing drugs. 
  This fact is also confirmed by the N2 adsorption-
desorption experiments carried out in gentamicin-loaded 
SBA-15 and in the same materials after the releasing of drug 
molecules. As it shown in Fig. (9), the release of the drug 
from the pores of SBA-15 yields a surface area and pore 
volume very close to the value for as-synthesized SBA-15 
(usually SBET = 800 m
2/g and VP = 1.2 cm
3/g). The pore di-
ameter is also larger after the release of gentamicin since the 
adsorbed drug molecules are occupying part of the surface 
area of the mesopores, confirming that this is the mainly 
location for the loaded drug. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (8). Scheme of the processes of drug loading and release. XRD 
patterns of SBA-15 ordered mesoporous materials loaded with gen-
tamicin and after the drug release. 
 
 
 
 
 
 
 
 
 
 
Fig. (9). N2 adsorption isotherms and surface area values of SBA-
15 ordered mesoporous materials loaded with gentamicin and after 
the drug release. 
  The release kinetics of the drug is usually studied as a 
function of time in order to determine the rate constants for 
desorption of drug molecules from the mesopores. It is worth 
mentioning that generally for mesoporous materials, the re-
lease profiles exhibit a pronounced initial burst release effect 
in the very initial testing time, followed by a very slow re-
lease pattern. The initial burst is attributed to the immediate 
dissolution and release of the portion of the drug located on 
and near the surface of the pore entrances. In addition, it is 
also commonly observed in release profiles that the complete 
desorption of the drug is seldom found. This fact is usually 
attributed to the equilibrium achieved at the end of the 
desorption process that favors the partial retention of the 
drug in the mesopores. This is more evident in the case of 
functionalized mesoporous matrices, where the interaction 
between the drug molecules and the modified silica walls is 
stronger [74]. 6    The Open Biomedical Engineering Journal, 2008, Volume 2  Vallet-Regí and Balas 
  Silanol groups are effectively present in the walls of sil-
ica mesoporous materials. This is a common feature with the 
above-described bioactive glasses. If the same bioactivity 
tests are performed in order to determine if an apatite layer 
can grow on the surface of silica-based mesoporous materi-
als and there is a positive response, we would have another 
alternative material for bone regeneration, with the added 
value of confining inside the pores not only drugs, also pep-
tides and other species that accelerate the bone regeneration. 
This is depicted in Fig. (10) and certainly, the results have 
been positive [16,76]. A layer built up of apatite nanocrystals 
grows on the surface of the mesoporous material, throughout 
the process, the mesoporous structure remains with few 
damages. Therefore, we are dealing with materials that ex-
hibit the ability to regenerate bone, and the option of con-
taining molecules to contribute in this process [62,77]. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (10). Scheme of the similarities, in terms of silanol (Si-OH) 
covering of the surface, between bioactive sol-gel glasses and or-
dered mesoporous materials. TEM image and ED pattern showing 
the formation of apatite on the surface of ordered mesoporous silica 
after soaking in SBF. 
5. TEMPLATE GLASSES 
  In the preceding pages, it has been presented the state-of-
the-art in the research in silica materials for biomedical ap-
plications. The synthesis methods of mesoporous silica can 
be used for producing materials with the same compositions 
of bioactive glasses. In this way, the proper combination of 
both the excellent bioactive behavior of the glasses presented 
in Section 3 with the open texture and large surface areas of 
mesoporous materials will yield materials with potential ap-
plications in the biomedical fields.  
  These so-called template glasses are, in fact, derived 
from the use of micellar surfactants in the synthesis of 
equivalent compositions to those of bioactive glasses. The 
template glasses have to be synthesized employing a varia-
tion of the common preparation procedure of the mesoporous 
materials, for avoiding the precipitation of undesired phases 
during the synthesis. This modified procedure is known as 
the evaporation induced self-assembly (EISA) method [78], 
which is based in the formation of the micelle surfactant dur-
ing the elimination of the solvent by evaporation. This 
method ensures the incorporation of Ca
2+ cations in the SiO2 
matrix, which are responsible for the enhancement of the 
bioactive behavior. 
  When comparing the results of bioactivity tests and sur-
face area analysis of both conventional sol-gel glasses and 
template glasses, several facts can be observed. First, as it 
can be seen in the TEM image of Fig. (11), there is an or-
dered mesostructure and subsequently an opener texture than 
that observed for conventional sol-gel glasses. Moreover, the 
surface area of the template glasses is approximately the 
double of that found for equivalent sol-gel glasses, in terms 
of SiO2 content, as it can be seen in the N2 adsorption iso-
therms of Fig. (12). This is attributed to the presence of an 
ordered mesoporosity that would potentially lead to a better 
and more homogeneous adsorption of drugs and a higher 
contact area for the physiological fluids. This fact allows 
predicting that the kinetics of the apatite formation shall be 
much higher than that found for sol-gel glasses [18]. 
 
 
 
 
 
 
 
 
 
Fig. (11). TEM image, Fourier-transform ED image and XRD pat-
tern of one template glass with composition 85% SiO2, 10% CaO 
and 5% P2O5. 
  Indeed, the template glasses are more bioactive, in terms 
of the nucleation and growth of apatite on the surface of ma-
terials, than the conventional sol-gel glasses. The SEM im-
ages in Fig. (12) show that the surface of template glasses 
with large SiO2 content and a highly ordered mesostructure, 
is fully covered with an apatite layer within less than one 
single day of immersion in physiological conditions in vitro.  
 
 
 
 
 
 
 
 
 
 
Fig. (12). SEM images of one template glass with composition 85% 
SiO2, 10% CaO and 5% P2O5 after soaking in SBF for several peri-
ods. The comparison of the N2 adsorption isotherms of the template 
glass with a parent glass with similar composition is shown. 
6. DISCUSSION 
  Along the present review, our aim was condensing the 
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applications. Some of them are currently in clinical use like 
the bioglass, glass-ceramics, silica nanospheres and Fe2O3-
doped silica nanospheres for magnetic targeting. Some other 
silica-based materials, like star gels, template glasses and 
ordered mesoporous materials are nowadays under testing 
and the initial assays do confirm that can be used for clinical 
applications. 
  Among all the medical applications that are described for 
these materials, we have pointed up two of them in this re-
view. One of them was the use of these materials in the 
preparation of bioactive devices, since them show possibility 
to regenerate the bone tissue. In this classification, we in-
cluded the bioglasses, glass ceramics, star gels, template 
glasses and ordered mesoporous materials. On the other 
hand, the silica-based materials can hold and release drugs 
and biologically active intermediates. In some cases, such 
molecules are encapsulated, as in the case of silica nano-
spheres, and in other by showing an ordered mesoporous 
ceramic matrix that allows hosting molecules for a controlled 
delivery in the adequate location in the physiological envi-
ronment. 
  Summarizing, all this is shown in the scheme of Fig. 
(13). From all the reported data for silica materials useful for 
the medical practice, it can be deduced that the work in this 
area is just beginning. The possibilities are enormous, not 
only in the work that is in progress for processing these silica 
materials as pieces and devices with designed and hierarchi-
cal porosity, similar to that found in the bones of vertebrates. 
Such silica-based materials, therefore, could be excellent 
choices for designing substrates for tissue engineering. 
7. CONCLUSIONS 
  Different silica-based materials can be employed for de-
signing devices for biomedicine either for drug delivery sys-
tems or for bioactive materials in prosthetic applications. 
The current research is being focused in the development of 
devices that serve as clinical materials combining the above 
mentioned scopes. These silica-based systems are excellent 
candidates for designing substrates for biotechnology. 
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